Lantern Pharma(LTRN) - 2024 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 001-39318 46-3973463 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 1920 McKinney Avenue, 7th Floor Dallas, Texas 75201 (Address of Principal Executive Offices) (Zip Code) Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $0.0001 par value LTRN The Nasdaq Stock Market FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 ...